- The Wall Street Journal•1 hour ago
Biogen’s settlement with Forward Pharma removes a major risk for the stock.
- Motley Fool•7 hours ago
Despite big declines for the market, these stocks climbed. Find out why.
- TheStreet.com•7 hours ago
Shares of Biogen were lower Tuesday after resolving a dispute with Forward Pharma over its multiple sclerosis drug.
BIIB : Summary for Biogen Inc. - Yahoo Finance
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||279.02 x 100|
|Ask||284.23 x 100|
|Day's Range||281.08 - 286.32|
|52 Week Range||223.02 - 333.65|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.01|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|